To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.
Study Type
OBSERVATIONAL
Enrollment
1,568
Unnamed facility
Nagoya, Japan
Unnamed facility
Osaka, Japan
Unnamed facility
Tokyo, Japan
Incidence of adverse drug reactions
Time frame: 52 weeks
Recurrence rate of peptic ulcer
Time frame: 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.